Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Porphine is the simplest member and parent compound of the porphyrin family, a class of heterocyclic macrocyclic organic compounds consisting of four pyrrole subunits joined by methine bridges. While porphine itself is primarily of theoretical interest due to its poor solubility, its substituted derivatives—porphyrins—are biologically indispensable, serving as the functional core for essential cofactors such as heme in hemoglobin and chlorophyll in plants. In therapeutic contexts, porphyrin-based molecules are primarily utilized as photosensitizers in photodynamic therapy (PDT); these compounds preferentially accumulate in malignant tissues and, upon activation by specific wavelengths of light, generate reactive singlet oxygen that induces localized cell death. Beyond oncology, the porphyrin biosynthetic pathway is clinically significant in the pathology of porphyrias, a group of metabolic disorders where enzyme deficiencies lead to the toxic accumulation of porphyrin intermediates. Additionally, porphyrins like heme serve as critical targets for certain antimalarial drugs, which interfere with the parasite's ability to detoxify these molecules during hemoglobin digestion.
Generation of reactive oxygen species (ROS) such as singlet oxygen through light-activated photosensitization; competitive binding and inhibition of heme biocrystallization in Plasmodium parasites.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Porphine.